ELRIG announces Drug Discovery Digital
Due to the restrictions imposed by the global COVID-19 pandemic, ELRIG's 14th Drug Discovery, will be a virtual event.
Taking place over a 2 week period from 6 - 16 October 2020, the event will offer the same world-class science and exhibition visitors would expect from the conference but from the comfort of your own desktop and with programming to fit around your daily schedule.
Drug Discovery Digital will still include leadding talks and examples of new directions in drug discovery. ELRIG’s scientific programme will feature over 50 speakers with eight main session tracks and two plenary keynote speakers. The tracks for 2020 are:
Innovations in Chemistry to discover new medicines
New Modalities to treat disease
Patient relevant models for drug discovery
Atypical and orphan GPCRs as targets for drug discovery hosted by the British Pharmacological Society
Multi Omic approaches to deliver new medicines
Better Hits = Better therapeutics?
Addressing the challenges of Infection – how do we develop new treatments?
Cancer Research UK track
Plenary Keynote Speakers
Best Practice Approaches & Overcoming Potential Challenges in Targeting Kinases for Drug Discovery READ MORE
3D Cell Culture - A Rapidly Emerging Technique for Drug Discovery READ MORE
Collaboration launches Autobahn Labs, novel early stage drug discovery incubator READ MORE
PharmEnable raises £1.8 million for drug discovery expansion READ MORE
How drug discovery software is inspiring US high-school students READ MORE
Cost-effective drug discovery: How this AI system aims to assist READ MORE
AI start-up with platform that speeds up drug discovery scoops $1 million investment READ MORE